undamentalytics Newsletter

Skoufalos Ioannis: insider trades

Officer at Procter & Gamble. No open-market purchases and 34 sales not made under a pre-set plan, reported from February 28, 2012 to May 15, 2019.

What happened after Skoufalos Ioannis’s sales?

After their sales, the shares moved −0.3% against the index over 12 months on average (a negative figure means selling was the right call); 53% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Skoufalos Ioannis: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 34 −0.1% −2.4% 56% 8 −0.23 0.82 No reliable evidence
Sales, 12 months after the report 34 −0.3% −5.0% 53% 8 −0.09 0.93 No reliable evidence
Sales, 12 months after the trade 34 −0.2% −5.7% 53% 8 −0.03 0.98 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Procter & Gamble PG Global Product Supply Officer034February 28, 2012May 15, 2019

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 15, 2019May 15, 2019 PG Sale $2,214,783 +9.9%+7.2%+7.4%
April 29, 2019April 26, 2019 PG Sale $2,105,000 +11.0%+11.0%+14.0%
February 1, 2019February 1, 2019 PG Sale $2,860,796 +0.4%+8.2%+9.4%
November 19, 2018November 16, 2018 PG Sale $3,176,401 +2.5%+14.5%+16.8%
November 13, 2018November 12, 2018 PG Sale $1,858,200 +4.4%+14.9%+18.2%
November 9, 2018November 9, 2018 PG Sale $715,088 +5.8%+18.2%+19.2%
August 27, 2018August 24, 2018 PG Sale $499,020 +19.1%+46.7%+47.3%
August 23, 2018August 22, 2018 PG Sale $393,463 +18.8%+47.3%+43.5%
June 12, 2018June 11, 2018 PG Sale $317,226 +5.2%+44.2%+40.6%
November 20, 2017November 17, 2017 PG Sale $255,600 −14.2%+2.9%+2.9%
August 17, 2017August 15, 2017 PG Sale $266,272 −9.8%−26.4%−24.2%
May 22, 2017May 22, 2017 PG Sale $334,253 +5.9%−27.1%−27.3%
March 1, 2017February 28, 2017 PG Sale $158,393 −4.9%−25.0%−28.2%
February 10, 2017February 9, 2017 PG Sale $886,500 −5.2%−21.4%−22.7%
January 31, 2017January 31, 2017 PG Sale $870,000 −5.5%−24.8%−24.7%
August 12, 2016August 12, 2016 PG Sale $1,836,581 −2.5%−5.5%−6.5%
August 9, 2016August 9, 2016 PG Sale $743,734 +3.2%−4.6%−5.4%
August 8, 2016August 5, 2016 PG Sale $847,138 +3.3%−5.4%−6.0%
March 1, 2016February 26, 2016 PG Sale $1,015,750 −6.3%−8.6%−8.5%
February 18, 2016February 17, 2016 PG Sale $1,221,249 −8.1%−10.1%−10.4%
January 28, 2016January 27, 2016 PG Sale $582,264 −8.2%−10.4%−11.1%
November 16, 2015November 16, 2015 PG Sale $184,733 +15.9%+6.1%+6.3%
August 19, 2015August 18, 2015 PG Sale $186,746 +0.7%+12.7%+13.4%
May 29, 2015May 29, 2015 PG Sale $633,600 −3.6%+5.0%+5.8%
February 25, 2015February 23, 2015 PG Sale $1,875,320 −7.1%+4.3%+6.2%
February 19, 2015February 19, 2015 PG Sale $205,138 −6.0%+6.0%+6.0%
October 29, 2014October 29, 2014 PG Sale $234,333 −3.2%−15.7%−15.6%
August 19, 2014August 19, 2014 PG Sale $112,833 +3.2%−12.5%−14.6%
May 13, 2014May 9, 2014 PG Sale $1,119,461 −2.4%−12.1%−13.8%
April 28, 2014April 25, 2014 PG Sale $552,177 −9.2%−14.5%−13.3%
November 25, 2013November 25, 2013 PG Sale $1,167,098 −10.0%−8.8%−9.6%
May 29, 2013May 28, 2013 PG Sale $551,338 −1.5%−13.2%−15.2%
January 30, 2013January 28, 2013 PG Sale $176,520 −3.0%−16.4%−11.2%
February 28, 2012February 27, 2012 PG Sale $506,806 −3.6%+3.2%+5.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Skoufalos Ioannis traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.